In these commentaries, members of the editorial board of Population Health, Equity & Outcomes present their ideas for fixes to the US health care system that could guide health policy efforts post election.
How Cold Weather Worsens Chronic Conditions and What Patients Can Do
ASH 2024 Showcases Real-World Data Demonstrating Efficacy of Ruxolitinib Across Multiple Conditions
Mass-Mailed Stool Tests Helped Improve Odds of Adherence, CRC Test Return
Fixed-Duration Acalabrutinib Plus Venetoclax Beats Chemoimmunotherapy in First-Line CLL; Adding Obinutuzumab Boosts PFS
Dr Oz's Medicare Proposals Face Scrutiny From Democrats
Mind the Gap: Addressing Pediatric Sleep Disparities and the Role of Sleep Variability
Ambient Toxins Linked to Disabilities in Minority Schoolchildren
Socioeconomic Factors Limit Access to Stem Cell Transplantation in AML
Health Equity & Access Weekly Roundup: December 7, 2024
New Data Reinforce Iptacopan's Role in Transforming PNH Care With Hemoglobin, QOL Gains
Advancing Women's Health: CVS Health Leader on Access, Technology, and Breaking Stigmas
Who Lives to 100? New Research Reveals Differences Across Racial, Ethnic Groups
Despite Medicare, US Seniors Struggle to Afford Care Compared With International Peers
Uncovering the Gaps: Study Sheds Light on Racial Disparities in IPF Outcomes
Navigating Healthcare Access and Decision-Making
Vowst as a Potential Option for Patients With Recurrent C Difficile Infections
ASCO 2024 and Beyond: Addressing NSCLC Unmet Needs and Future Research Directions
Implementing CRM Learnings and Utilization of Telehealth
How Anti–CD-38 Antibodies Are Changing the Standard of Myeloma Care
Shorter Duration of Venetoclax Possible for Some Patients With Newly Diagnosed AML
Linvoseltamab Shows Durable Efficacy, Manageable Safety in R/R Multiple Myeloma
Insights on Managing Cough Symptoms in Patients With IPF
Key Data Supporting the Use of Rebyota in Patients With Recurrent C Difficile Infections
Unveiling Disparities of Patients With Lymphoma by Race, Ethnicity, and Socioeconomic Status
ASH 2024 Showcases Real-World Data Demonstrating Efficacy of Ruxolitinib Across Multiple Conditions
Shorter Duration of Venetoclax Possible for Some Patients With Newly Diagnosed AML
Fixed-Duration Acalabrutinib Plus Venetoclax Beats Chemoimmunotherapy in First-Line CLL; Adding Obinutuzumab Boosts PFS
Linvoseltamab Shows Durable Efficacy, Manageable Safety in R/R Multiple Myeloma
Dallas Nephrology Associates’ Journey to Value-Based Care
An Integrated Practice Unit Tool for the Military Health System
Disconnects Between Provider Network Directories and Patient Preferences
Searching for the Policy-Relevant Treatment Effect in Medicare’s ACO Evaluations
Out-of-Pocket Spending for Cardiac Rehabilitation and Adherence Among US Adults
The Health Care Price Crisis Needs Policy Solutions
To Improve Clinical Trial Equity in Multiple Myeloma, Just Ask
Collaborating for Cancer Care Equity: Community and Academic Insights
Elevating Value in Cancer Care With Innovations, Accessibility, Equity
Beyond McKesson and Florida Cancer Specialists, Deals Are Reshaping Community Oncology
Evidence-Based Guidelines Point to Leap in Care for Hypertrophic Cardiomyopathy
ASH Annual Meeting Coverage: Highlighting the Recent Updates in TKI Use in the Treatment of CML – Insights and Application for Managed Care
Advances and Best Practices for Managed Care Pharmacists in the Treatment of Heart Failure with Preserved Ejection Fraction
Navigating the Evolving Landscape of HER2-Positive Early-Stage Breast Cancer: Considerations for Managed Care
Child Abuse: Responsibilities and Protection of the Reporter
Recent Advances in BCMA-Directed Treatment in Multiple Myeloma: Insights and Application for Managed Care
Managed Care Approaches to Improve Outcomes in Frontline Therapy for Renal Cell Carcinoma
Challenges in Treatment of Desmoid Tumors and Managed Care Solutions
Desmoid Tumors: What Managed Care Professionals Need to Know to Manage These Unpredictable Tumors, featuring a Pharmacy Focus Podcast
Navigating the Advances in the Treatment of Geographic Atrophy: Updates and Strategies for Managed Care